Global Next Generation Probiotics Market

Next Generation Probiotics Comprehensive Study by Application (Autoimmune Diseases, Glucose Management, Inflammatory Bowel Disease, Others), Category (Akkermansia Muciniphila, Faecalibacterium Prausnitzii, Bacteroides Fragilis, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Players and Region - Global Market Outlook to 2030

Next Generation Probiotics Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Next Generation Probiotics
Next generation probiotics is a broad term that refers to a new generation of probiotic products that are designed to provide enhanced benefits for human health. Probiotics are live microorganisms that, when consumed in adequate amounts, offer health benefits to the host. The NGPs enhance gastrointestinal immunity, maintain intestinal barrier integrity, produce beneficial metabolites, act against pathogens, and improve immunotherapy efficacy.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Major players have adopted various strategies such as expansions, investments, new product launches, and collaborations as their preferred strategies. Apart from this, the players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Next Generation Probiotics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Pendulum Therapeutics Inc. (United States), Winclove Probiotics B.V. (Netherlands), Metabogen AB (Sweden), Exeliom Biosciences (France), TargEDys (France), Chr. Hansen A/S (Denmark), YSOPIA Bioscience (France), BioGaia (Sweden), A-Mansia Biotech (Belgium) and Evolve Biosystems (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Next Generation Probiotics market by , Application (Autoimmune Diseases, Glucose Management, Inflammatory Bowel Disease and Others) and Region.



On the basis of geography, the market of Next Generation Probiotics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Category, the sub-segment i.e. Akkermansia Muciniphila will boost the Next Generation Probiotics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Next Generation Probiotics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Use of Probiotics as Potential Biotherapeutic Agents

Market Growth Drivers:
Increasing Prevalence of Digestive Disorders and Rise in Awareness of the Importance of Gut Health among People

Challenges:
Highly Competitive With Numerous Players

Restraints:
Stringent Rules and Regulations for Product Approval

Opportunities:
Collaboration with Healthcare Professionals Such As Doctors, Nutritionists, and Dieticians, Presents an Opportunity for Market Growth

Market Leaders and their expansionary development strategies
In September 2022, TargEDys and Inoliva, have signed an agreement for the marketing and distribution of Satylia, a food supplement based on the next-generation probiotic Hafnia alvei HA4597, to the Turkish market
In July 2022, BioGaia launched a probiotic product to support children’s respiratory health, which aims to strengthen the immune system and support children’s upper respiratory health
In the United States, the FDA regulates probiotics as dietary supplements. The FDA's Center for Food Safety and Applied Nutrition (CFSAN) oversees the safety and labeling of dietary supplements, including probiotic products. Manufacturers of probiotics are required to comply with FDA regulations, including good manufacturing practices (GMPs) and labeling requirements.

Key Target Audience
Manufacturers, Suppliers, and Distributors, Potential Investors, Government Institutes, Regulatory Authorities, Research and Development Institutes, Market Research & Consulting Firms and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Autoimmune Diseases
  • Glucose Management
  • Inflammatory Bowel Disease
  • Others
By Category
  • Akkermansia Muciniphila
  • Faecalibacterium Prausnitzii
  • Bacteroides Fragilis
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Digestive Disorders
      • 3.2.2. Rise in Awareness of the Importance of Gut Health among People
    • 3.3. Market Challenges
      • 3.3.1. Highly Competitive With Numerous Players
    • 3.4. Market Trends
      • 3.4.1. Increasing Use of Probiotics as Potential Biotherapeutic Agents
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Next Generation Probiotics, by Application, Category, Distribution Channel and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Next Generation Probiotics (Value)
      • 5.2.1. Global Next Generation Probiotics by: Application (Value)
        • 5.2.1.1. Autoimmune Diseases
        • 5.2.1.2. Glucose Management
        • 5.2.1.3. Inflammatory Bowel Disease
        • 5.2.1.4. Others
      • 5.2.2. Global Next Generation Probiotics by: Category (Value)
        • 5.2.2.1. Akkermansia Muciniphila
        • 5.2.2.2. Faecalibacterium Prausnitzii
        • 5.2.2.3. Bacteroides Fragilis
        • 5.2.2.4. Others
      • 5.2.3. Global Next Generation Probiotics by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Pharmacies
      • 5.2.4. Global Next Generation Probiotics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Next Generation Probiotics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pendulum Therapeutics Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Winclove Probiotics B.V. (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Metabogen AB (Sweden)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Exeliom Biosciences (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. TargEDys (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Chr. Hansen A/S (Denmark)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. YSOPIA Bioscience (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BioGaia (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. A-Mansia Biotech (Belgium)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Evolve Biosystems (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Next Generation Probiotics Sale, by Application, Category, Distribution Channel and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Next Generation Probiotics (Value)
      • 7.2.1. Global Next Generation Probiotics by: Application (Value)
        • 7.2.1.1. Autoimmune Diseases
        • 7.2.1.2. Glucose Management
        • 7.2.1.3. Inflammatory Bowel Disease
        • 7.2.1.4. Others
      • 7.2.2. Global Next Generation Probiotics by: Category (Value)
        • 7.2.2.1. Akkermansia Muciniphila
        • 7.2.2.2. Faecalibacterium Prausnitzii
        • 7.2.2.3. Bacteroides Fragilis
        • 7.2.2.4. Others
      • 7.2.3. Global Next Generation Probiotics by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Pharmacies
      • 7.2.4. Global Next Generation Probiotics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Next Generation Probiotics: by Application(USD Million)
  • Table 2. Next Generation Probiotics Autoimmune Diseases , by Region USD Million (2018-2023)
  • Table 3. Next Generation Probiotics Glucose Management , by Region USD Million (2018-2023)
  • Table 4. Next Generation Probiotics Inflammatory Bowel Disease , by Region USD Million (2018-2023)
  • Table 5. Next Generation Probiotics Others , by Region USD Million (2018-2023)
  • Table 6. Next Generation Probiotics: by Category(USD Million)
  • Table 7. Next Generation Probiotics Akkermansia Muciniphila , by Region USD Million (2018-2023)
  • Table 8. Next Generation Probiotics Faecalibacterium Prausnitzii , by Region USD Million (2018-2023)
  • Table 9. Next Generation Probiotics Bacteroides Fragilis , by Region USD Million (2018-2023)
  • Table 10. Next Generation Probiotics Others , by Region USD Million (2018-2023)
  • Table 11. Next Generation Probiotics: by Distribution Channel(USD Million)
  • Table 12. Next Generation Probiotics Hospital Pharmacies , by Region USD Million (2018-2023)
  • Table 13. Next Generation Probiotics Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 14. Next Generation Probiotics Online Pharmacies , by Region USD Million (2018-2023)
  • Table 15. South America Next Generation Probiotics, by Country USD Million (2018-2023)
  • Table 16. South America Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 17. South America Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 18. South America Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 19. Brazil Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 20. Brazil Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 21. Brazil Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 22. Argentina Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 23. Argentina Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 24. Argentina Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 25. Rest of South America Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 26. Rest of South America Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 27. Rest of South America Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 28. Asia Pacific Next Generation Probiotics, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 30. Asia Pacific Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 31. Asia Pacific Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 32. China Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 33. China Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 34. China Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 35. Japan Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 36. Japan Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 37. Japan Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 38. India Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 39. India Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 40. India Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 41. South Korea Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 42. South Korea Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 43. South Korea Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 44. Taiwan Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 45. Taiwan Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 46. Taiwan Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 47. Australia Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 48. Australia Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 49. Australia Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 53. Europe Next Generation Probiotics, by Country USD Million (2018-2023)
  • Table 54. Europe Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 55. Europe Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 56. Europe Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 57. Germany Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 58. Germany Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 59. Germany Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 60. France Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 61. France Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 62. France Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 63. Italy Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 64. Italy Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 65. Italy Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 66. United Kingdom Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 67. United Kingdom Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 68. United Kingdom Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 69. Netherlands Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 70. Netherlands Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 71. Netherlands Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 72. Rest of Europe Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 73. Rest of Europe Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 74. Rest of Europe Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 75. MEA Next Generation Probiotics, by Country USD Million (2018-2023)
  • Table 76. MEA Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 77. MEA Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 78. MEA Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 79. Middle East Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 80. Middle East Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 81. Middle East Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 82. Africa Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 83. Africa Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 84. Africa Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 85. North America Next Generation Probiotics, by Country USD Million (2018-2023)
  • Table 86. North America Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 87. North America Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 88. North America Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 89. United States Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 90. United States Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 91. United States Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 92. Canada Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 93. Canada Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 94. Canada Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 95. Mexico Next Generation Probiotics, by Application USD Million (2018-2023)
  • Table 96. Mexico Next Generation Probiotics, by Category USD Million (2018-2023)
  • Table 97. Mexico Next Generation Probiotics, by Distribution Channel USD Million (2018-2023)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Next Generation Probiotics: by Application(USD Million)
  • Table 109. Next Generation Probiotics Autoimmune Diseases , by Region USD Million (2025-2030)
  • Table 110. Next Generation Probiotics Glucose Management , by Region USD Million (2025-2030)
  • Table 111. Next Generation Probiotics Inflammatory Bowel Disease , by Region USD Million (2025-2030)
  • Table 112. Next Generation Probiotics Others , by Region USD Million (2025-2030)
  • Table 113. Next Generation Probiotics: by Category(USD Million)
  • Table 114. Next Generation Probiotics Akkermansia Muciniphila , by Region USD Million (2025-2030)
  • Table 115. Next Generation Probiotics Faecalibacterium Prausnitzii , by Region USD Million (2025-2030)
  • Table 116. Next Generation Probiotics Bacteroides Fragilis , by Region USD Million (2025-2030)
  • Table 117. Next Generation Probiotics Others , by Region USD Million (2025-2030)
  • Table 118. Next Generation Probiotics: by Distribution Channel(USD Million)
  • Table 119. Next Generation Probiotics Hospital Pharmacies , by Region USD Million (2025-2030)
  • Table 120. Next Generation Probiotics Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 121. Next Generation Probiotics Online Pharmacies , by Region USD Million (2025-2030)
  • Table 122. South America Next Generation Probiotics, by Country USD Million (2025-2030)
  • Table 123. South America Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 124. South America Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 125. South America Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 126. Brazil Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 127. Brazil Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 128. Brazil Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 129. Argentina Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 130. Argentina Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 131. Argentina Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 132. Rest of South America Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 133. Rest of South America Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 134. Rest of South America Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 135. Asia Pacific Next Generation Probiotics, by Country USD Million (2025-2030)
  • Table 136. Asia Pacific Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 137. Asia Pacific Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 138. Asia Pacific Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 139. China Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 140. China Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 141. China Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 142. Japan Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 143. Japan Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 144. Japan Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 145. India Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 146. India Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 147. India Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 148. South Korea Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 149. South Korea Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 150. South Korea Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 151. Taiwan Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 152. Taiwan Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 153. Taiwan Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 154. Australia Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 155. Australia Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 156. Australia Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 158. Rest of Asia-Pacific Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 159. Rest of Asia-Pacific Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 160. Europe Next Generation Probiotics, by Country USD Million (2025-2030)
  • Table 161. Europe Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 162. Europe Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 163. Europe Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 164. Germany Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 165. Germany Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 166. Germany Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 167. France Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 168. France Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 169. France Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 170. Italy Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 171. Italy Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 172. Italy Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 173. United Kingdom Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 174. United Kingdom Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 175. United Kingdom Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 176. Netherlands Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 177. Netherlands Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 178. Netherlands Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 179. Rest of Europe Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 180. Rest of Europe Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 181. Rest of Europe Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 182. MEA Next Generation Probiotics, by Country USD Million (2025-2030)
  • Table 183. MEA Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 184. MEA Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 185. MEA Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 186. Middle East Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 187. Middle East Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 188. Middle East Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 189. Africa Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 190. Africa Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 191. Africa Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 192. North America Next Generation Probiotics, by Country USD Million (2025-2030)
  • Table 193. North America Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 194. North America Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 195. North America Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 196. United States Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 197. United States Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 198. United States Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 199. Canada Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 200. Canada Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 201. Canada Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 202. Mexico Next Generation Probiotics, by Application USD Million (2025-2030)
  • Table 203. Mexico Next Generation Probiotics, by Category USD Million (2025-2030)
  • Table 204. Mexico Next Generation Probiotics, by Distribution Channel USD Million (2025-2030)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Next Generation Probiotics: by Application USD Million (2018-2023)
  • Figure 5. Global Next Generation Probiotics: by Category USD Million (2018-2023)
  • Figure 6. Global Next Generation Probiotics: by Distribution Channel USD Million (2018-2023)
  • Figure 7. South America Next Generation Probiotics Share (%), by Country
  • Figure 8. Asia Pacific Next Generation Probiotics Share (%), by Country
  • Figure 9. Europe Next Generation Probiotics Share (%), by Country
  • Figure 10. MEA Next Generation Probiotics Share (%), by Country
  • Figure 11. North America Next Generation Probiotics Share (%), by Country
  • Figure 12. Global Next Generation Probiotics share by Players 2023 (%)
  • Figure 13. Global Next Generation Probiotics share by Players (Top 3) 2023(%)
  • Figure 14. Global Next Generation Probiotics share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Pendulum Therapeutics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Pendulum Therapeutics Inc. (United States) Revenue: by Geography 2023
  • Figure 18. Winclove Probiotics B.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 19. Winclove Probiotics B.V. (Netherlands) Revenue: by Geography 2023
  • Figure 20. Metabogen AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 21. Metabogen AB (Sweden) Revenue: by Geography 2023
  • Figure 22. Exeliom Biosciences (France) Revenue, Net Income and Gross profit
  • Figure 23. Exeliom Biosciences (France) Revenue: by Geography 2023
  • Figure 24. TargEDys (France) Revenue, Net Income and Gross profit
  • Figure 25. TargEDys (France) Revenue: by Geography 2023
  • Figure 26. Chr. Hansen A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 27. Chr. Hansen A/S (Denmark) Revenue: by Geography 2023
  • Figure 28. YSOPIA Bioscience (France) Revenue, Net Income and Gross profit
  • Figure 29. YSOPIA Bioscience (France) Revenue: by Geography 2023
  • Figure 30. BioGaia (Sweden) Revenue, Net Income and Gross profit
  • Figure 31. BioGaia (Sweden) Revenue: by Geography 2023
  • Figure 32. A-Mansia Biotech (Belgium) Revenue, Net Income and Gross profit
  • Figure 33. A-Mansia Biotech (Belgium) Revenue: by Geography 2023
  • Figure 34. Evolve Biosystems (United States) Revenue, Net Income and Gross profit
  • Figure 35. Evolve Biosystems (United States) Revenue: by Geography 2023
  • Figure 36. Global Next Generation Probiotics: by Application USD Million (2025-2030)
  • Figure 37. Global Next Generation Probiotics: by Category USD Million (2025-2030)
  • Figure 38. Global Next Generation Probiotics: by Distribution Channel USD Million (2025-2030)
  • Figure 39. South America Next Generation Probiotics Share (%), by Country
  • Figure 40. Asia Pacific Next Generation Probiotics Share (%), by Country
  • Figure 41. Europe Next Generation Probiotics Share (%), by Country
  • Figure 42. MEA Next Generation Probiotics Share (%), by Country
  • Figure 43. North America Next Generation Probiotics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Pendulum Therapeutics Inc. (United States)
  • Winclove Probiotics B.V. (Netherlands)
  • Metabogen AB (Sweden)
  • Exeliom Biosciences (France)
  • TargEDys (France)
  • Chr. Hansen A/S (Denmark)
  • YSOPIA Bioscience (France)
  • BioGaia (Sweden)
  • A-Mansia Biotech (Belgium)
  • Evolve Biosystems (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 223 Pages 83 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Next Generation Probiotics Market Quantitative research analysis
Global Next Generation Probiotics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Pendulum Therapeutics Inc. (United States), Winclove Probiotics B.V. (Netherlands), Metabogen AB (Sweden), Exeliom Biosciences (France), TargEDys (France), Chr. Hansen A/S (Denmark), YSOPIA Bioscience (France), BioGaia (Sweden), A-Mansia Biotech (Belgium) and Evolve Biosystems (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Use of Probiotics as Potential Biotherapeutic Agents" is seen as one of major influencing trends for Next Generation Probiotics Market during projected period 2023-2030.
The Next Generation Probiotics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Next Generation Probiotics Market Report?

Have a Query? Click Here

Other Related Reports

Medical Manuka Honey Comprehensive Study by Application (Healthcare, Skin Care Industry, Others), Distribution Channel (Online, Offline), Category Type (K-Factor, K-Factor 12, K-Factor 16, K-Factor 2...
$ 3800
Digital Payment in Healthcare Comprehensive Study by Type (On-Premise, Cloud), By Enterprise size (Small size, Medium size, Large size), By Component (Solution, Service, Intelligence), Payment Mode...
$ 3800
Cell Therapy Market Comprehensive Study by Application (Musculoskeletal, Malignancies, Cardiovascular, Dermatology and Wounds, Other), Type (Autologous, Allogeneic), End User (Hospitals, Homecare, S...
$ 3800
Big Data in the Healthcare & Pharmaceutical Industry Comprehensive Study by Application (Financial Analytics, Clinical Data Analytics, Operational Analytics, Population Health Analytics), Deployment ...
$ 3800
Acupuncture- Comprehensive Study by Type (Needle Acupuncture, Moxibustion Acupuncture, Cupping, Auricular, Others), End-User (Hospitals, Speciality clinics, Wellness Centre, Others), Needle Type (Non...
$ 3800
United States Non-Invasive Prenatal Testing Comprehensive Study by Type (High & Average Risk, Low Risk), Application (0-12 weeks, 13-24 weeks, 25-36 weeks), Consumables (Assay Kits & Reagents, Dispos...
$ 3800